https://www.selleckchem.com/products/IC-87114.html
To compare the oncologic outcomes of liver resection (LR) and local ablation therapies for HCC. Although several studies have compared LR and local ablation therapies, the optimal treatment of choice for HCC within the Milan criteria remains controversial. We systemically searched the MEDLINE, Embase, and Cochrane Library databases for randomized control trials (RCTs) and matched nonrandomized trials (NRTs) that compared LR and local ablation therapies for HCC within the Milan criteria. The primary outcome was overall survival (OS). Se
Like
Comment
Share
